These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6437625)

  • 1. Interrelationship of cancer control and clinical research in the community.
    Enck RE
    CA Cancer J Clin; 1984; 34(6):340-4. PubMed ID: 6437625
    [No Abstract]   [Full Text] [Related]  

  • 2. Delaware/Christiana Care Community Clinical Oncology Program (CCOP): a National Cancer Institute clinical trials program.
    Price K
    Del Med J; 2007 Jun; 79(6):247-51. PubMed ID: 17621871
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trials in the community. The community clinical oncology program experience.
    Cobau CD
    Cancer; 1994 Nov; 74(9 Suppl):2694-700. PubMed ID: 7954289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community Clinical Oncology Program as a recruitment vehicle for cancer control research. The Southeast Cancer Control Consortium experience.
    Paskett ED; Cooper MR; DeGraffinreid CR; Spurr CL; Dolecek TA
    N C Med J; 1995 Jun; 56(6):283-6. PubMed ID: 7603584
    [No Abstract]   [Full Text] [Related]  

  • 5. Oncology services in United States.
    Murphy GP; Gerlach RW
    N Y State J Med; 1979 Jul; 79(8):1248-54. PubMed ID: 287926
    [No Abstract]   [Full Text] [Related]  

  • 6. Attitudes of CCOP physicians toward clinical trials and protocol accrual.
    Vinciguerra V; Moore T
    Prog Clin Biol Res; 1990; 339():401-7. PubMed ID: 2392432
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluating organizational design to assure technology transfer: the case of the Community Clinical Oncology Program.
    Kaluzny AD; Ricketts T; Warnecke R; Ford L; Morrissey J; Gillings D; Sondik EJ; Ozer H; Goldman J
    J Natl Cancer Inst; 1989 Nov; 81(22):1717-25. PubMed ID: 2681795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
    Buchanan DR; White JD; O'Mara AM; Kelaghan JW; Smith WB; Minasian LM
    J Clin Oncol; 2005 Sep; 23(27):6682-9. PubMed ID: 16170176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organizations and structures that facilitate community research.
    Coltman CA
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):107-11. PubMed ID: 8091235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Community Clinical Oncology Program (CCOP) story: review of community oncologists' experiences with clinical research trials in cancer with an emphasis on the CCOP of the National Cancer Institute between 1982 and 1987.
    Frelick RW
    J Clin Oncol; 1994 Aug; 12(8):1718-23. PubMed ID: 8040683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cancer program product line: can primary diagnosis be used as an estimate.
    Baum HM; Gordon D
    Prog Clin Biol Res; 1988; 278():203-10. PubMed ID: 3062623
    [No Abstract]   [Full Text] [Related]  

  • 12. Community Clinical Oncology Program celebrates 20 years of trials and a few tribulations.
    Moulton G
    J Natl Cancer Inst; 2003 Dec; 95(24):1822-4. PubMed ID: 14679150
    [No Abstract]   [Full Text] [Related]  

  • 13. Performance in quasi-firms: an example from the Community Clinical Oncology Program.
    Lacey LM; Hynes DM; Kaluzny AD
    J Health Hum Resour Adm; 1992; 14(3):307-26. PubMed ID: 10118501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of thematic evaluation in program assessment: the case of the Community Clinical Oncology Program.
    Gillings D; Ricketts TC; Barnsley JM; Kaluzny AD; Ford L; Warnecke R; Sondik E
    J Med Syst; 1990 Aug; 14(4):197-211. PubMed ID: 2093740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using a community cancer treatment trials network for cancer prevention and control research: challenges and opportunities.
    Kaluzny AD; Lacey LM; Warnecke R; Morrissey JP; Sondik E; Ford L
    Cancer Epidemiol Biomarkers Prev; 1994; 3(3):261-9. PubMed ID: 8019377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NCI expects to enlist community hospitals in cancer trials soon.
    Med World News; 1982 Mar; 23(7):13-4. PubMed ID: 10254711
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of managed care and competition on community-based clinical research.
    Carpenter WR; Weiner BJ; Kaluzny AD; Domino ME; Lee SY
    Med Care; 2006 Jul; 44(7):671-9. PubMed ID: 16799362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program.
    Kaluzny A; Brawley O; Garson-Angert D; Shaw J; Godley P; Warnecke R; Ford L
    J Natl Cancer Inst; 1993 Dec; 85(23):1945-50. PubMed ID: 8230286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer control activities of Community Clinical Oncology Program (CCOP) applicants.
    Frelick RW; Yates JW; Dunlap W; Foster R
    Prog Clin Biol Res; 1984; 156():23-32. PubMed ID: 6473431
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of the community oncologist.
    Yates JW
    Urology; 1984 Apr; 23(4 Suppl):149-52. PubMed ID: 6369717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.